{"id":109166,"date":"2021-05-30T11:13:50","date_gmt":"2021-05-30T11:13:50","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=109166"},"modified":"2021-05-30T11:13:50","modified_gmt":"2021-05-30T11:13:50","slug":"phencyclidine-abuse","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/","title":{"rendered":"Phencyclidine abuse"},"content":{"rendered":"

Phencyclidine (PCP) was originally developed as an intra\u00ac venous surgical anesthetic in the 1950s. It was used routinely in veterinary medicine, but clinical trials with humans were discontinued in 1965 due to a number of adverse side effects, including agitation, delirium, and irrational behavior (National Institute on Drug Abuse, 2001b). It is classified as a dissociative anesthetic because users experience a trancelike, out-of-body feeling as well as a detachment from their environment (National Institute on Drug Abuse, 2001a).<\/p>\n

\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Phencyclidine (PCP) was originally developed as an intra\u00ac venous surgical anesthetic in the 1950s. It was used routinely in veterinary medicine, but clinical trials with humans were discontinued in 1965 due to a number of adverse side effects, including agitation, delirium, and irrational behavior (National Institute on Drug Abuse, 2001b). It is classified as a […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-109166","post","type-post","status-publish","format-standard","hentry","category-p"],"yoast_head":"\nPhencyclidine abuse - Definition of Phencyclidine abuse<\/title>\n<meta name=\"description\" content=\"Phencyclidine (PCP) was originally developed as an intra\u00ac venous surgical anesthetic in the 1950s. It was used routinely in veterinary medicine, but clinical trials with humans were discontinued in 1965 due to a number of adverse side effects, including agitation, delirium, and irrational behavior (National Institute on Drug Abuse, 2001b). It is classified as a dissociative anesthetic because users experience a trancelike, out-of-body feeling as well as a detachment from their environment (National Institute on Drug Abuse, 2001a).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Phencyclidine abuse - Definition of Phencyclidine abuse\" \/>\n<meta property=\"og:description\" content=\"Phencyclidine (PCP) was originally developed as an intra\u00ac venous surgical anesthetic in the 1950s. It was used routinely in veterinary medicine, but clinical trials with humans were discontinued in 1965 due to a number of adverse side effects, including agitation, delirium, and irrational behavior (National Institute on Drug Abuse, 2001b). It is classified as a dissociative anesthetic because users experience a trancelike, out-of-body feeling as well as a detachment from their environment (National Institute on Drug Abuse, 2001a).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-30T11:13:50+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/\",\"name\":\"Phencyclidine abuse - Definition of Phencyclidine abuse\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-30T11:13:50+00:00\",\"dateModified\":\"2021-05-30T11:13:50+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Phencyclidine (PCP) was originally developed as an intra\u00ac venous surgical anesthetic in the 1950s. It was used routinely in veterinary medicine, but clinical trials with humans were discontinued in 1965 due to a number of adverse side effects, including agitation, delirium, and irrational behavior (National Institute on Drug Abuse, 2001b). It is classified as a dissociative anesthetic because users experience a trancelike, out-of-body feeling as well as a detachment from their environment (National Institute on Drug Abuse, 2001a).\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Phencyclidine abuse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Phencyclidine abuse - Definition of Phencyclidine abuse","description":"Phencyclidine (PCP) was originally developed as an intra\u00ac venous surgical anesthetic in the 1950s. It was used routinely in veterinary medicine, but clinical trials with humans were discontinued in 1965 due to a number of adverse side effects, including agitation, delirium, and irrational behavior (National Institute on Drug Abuse, 2001b). It is classified as a dissociative anesthetic because users experience a trancelike, out-of-body feeling as well as a detachment from their environment (National Institute on Drug Abuse, 2001a).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/","og_locale":"en_US","og_type":"article","og_title":"Phencyclidine abuse - Definition of Phencyclidine abuse","og_description":"Phencyclidine (PCP) was originally developed as an intra\u00ac venous surgical anesthetic in the 1950s. It was used routinely in veterinary medicine, but clinical trials with humans were discontinued in 1965 due to a number of adverse side effects, including agitation, delirium, and irrational behavior (National Institute on Drug Abuse, 2001b). It is classified as a dissociative anesthetic because users experience a trancelike, out-of-body feeling as well as a detachment from their environment (National Institute on Drug Abuse, 2001a).","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/","og_site_name":"Glossary","article_published_time":"2021-05-30T11:13:50+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/","name":"Phencyclidine abuse - Definition of Phencyclidine abuse","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-30T11:13:50+00:00","dateModified":"2021-05-30T11:13:50+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Phencyclidine (PCP) was originally developed as an intra\u00ac venous surgical anesthetic in the 1950s. It was used routinely in veterinary medicine, but clinical trials with humans were discontinued in 1965 due to a number of adverse side effects, including agitation, delirium, and irrational behavior (National Institute on Drug Abuse, 2001b). It is classified as a dissociative anesthetic because users experience a trancelike, out-of-body feeling as well as a detachment from their environment (National Institute on Drug Abuse, 2001a).","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/phencyclidine-abuse\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Phencyclidine abuse"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=109166"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109166\/revisions"}],"predecessor-version":[{"id":109167,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109166\/revisions\/109167"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=109166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=109166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=109166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}